These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32217089)

  • 1. SGLT1 participates in the development of vascular cognitive impairment in a mouse model of small vessel disease.
    Ishida N; Saito M; Sato S; Koepsell H; Taira E; Hirose M
    Neurosci Lett; 2020 May; 727():134929. PubMed ID: 32217089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease.
    Ishida N; Saito M; Sato S; Tezuka Y; Sanbe A; Taira E; Hirose M
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00869. PubMed ID: 34586752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene deletion of the Na
    Nespoux J; Patel R; Hudkins KL; Huang W; Freeman B; Kim YC; Koepsell H; Alpers CE; Vallon V
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1201-F1210. PubMed ID: 30995111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of interferon-regulatory factor-1 results in cognitive impairment.
    Mogi M; Iwanami J; Wang XL; Tsukuda K; Kan-No H; Bai HY; Shan BS; Higaki A; Min LJ; Horiuchi M
    Hypertens Res; 2018 Oct; 41(10):809-816. PubMed ID: 30082820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet.
    Mühlemann M; Zdzieblo D; Friedrich A; Berger C; Otto C; Walles H; Koepsell H; Metzger M
    Mol Metab; 2018 Jul; 13():67-76. PubMed ID: 29859847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor and cognitive impairment in a mouse model of ischemic carotid artery disease.
    Hattori Y; Kitamura A; Tsuji M; Nagatsuka K; Ihara M
    Neurosci Lett; 2014 Oct; 581():1-6. PubMed ID: 25123442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RS1 (Rsc1A1) deficiency limits cerebral SGLT1 expression and delays brain damage after experimental traumatic brain injury.
    Sebastiani A; Greve F; Gölz C; Förster CY; Koepsell H; Thal SC
    J Neurochem; 2018 Oct; 147(2):190-203. PubMed ID: 30022488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia.
    Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Kan-no H; Chisaka T; Bai HY; Shan BS; Kukida M; Horiuchi M
    J Am Soc Hypertens; 2015 Apr; 9(4):250-6. PubMed ID: 25753301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mouse model of subcortical infarcts with dementia.
    Hattori Y; Enmi J; Kitamura A; Yamamoto Y; Saito S; Takahashi Y; Iguchi S; Tsuji M; Yamahara K; Nagatsuka K; Iida H; Ihara M
    J Neurosci; 2015 Mar; 35(9):3915-28. PubMed ID: 25740520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-oxidative and Anti-apoptotic Effects of Acupuncture: Role of Thioredoxin-1 in the Hippocampus of Vascular Dementia Rats.
    Zhu W; Wang XR; Du SQ; Yan CQ; Yang NN; Lin LL; Shi GX; Liu CZ
    Neuroscience; 2018 May; 379():281-291. PubMed ID: 29592844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting outcome of Morris water maze test in vascular dementia mouse model with deep learning.
    Higaki A; Mogi M; Iwanami J; Min LJ; Bai HY; Shan BS; Kukida M; Kan-No H; Ikeda S; Higaki J; Horiuchi M
    PLoS One; 2018; 13(2):e0191708. PubMed ID: 29415035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion.
    Toyama K; Koibuchi N; Uekawa K; Hasegawa Y; Kataoka K; Katayama T; Sueta D; Ma MJ; Nakagawa T; Yasuda O; Tomimoto H; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):616-25. PubMed ID: 24371084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia.
    Zhu Y; Saito K; Murakami Y; Asano M; Iwakura Y; Seishima M
    Neurosci Lett; 2006 Jan; 393(2-3):122-6. PubMed ID: 16356636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cerebral hypoperfusion in a mouse model of Alzheimer's disease: an additional contributing factor of cognitive impairment.
    Lee JS; Im DS; An YS; Hong JM; Gwag BJ; Joo IS
    Neurosci Lett; 2011 Feb; 489(2):84-8. PubMed ID: 21134418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNA-126 in vascular cognitive impairment in mice.
    Yu P; Venkat P; Chopp M; Zacharek A; Shen Y; Ning R; Liang L; Li W; Zhang L; Landschoot-Ward J; Jiang R; Chen J
    J Cereb Blood Flow Metab; 2019 Dec; 39(12):2497-2511. PubMed ID: 30215264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of Na
    Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT1 sugar transporter/sensor is required for post-oral glucose appetition.
    Sclafani A; Koepsell H; Ackroff K
    Am J Physiol Regul Integr Comp Physiol; 2016 Apr; 310(7):R631-9. PubMed ID: 26791832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved glycemic control in mice lacking Sglt1 and Sglt2.
    Powell DR; DaCosta CM; Gay J; Ding ZM; Smith M; Greer J; Doree D; Jeter-Jones S; Mseeh F; Rodriguez LA; Harris A; Buhring L; Platt KA; Vogel P; Brommage R; Shadoan MK; Sands AT; Zambrowicz B
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E117-30. PubMed ID: 23149623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice.
    Sawa Y; Saito M; Ishida N; Ibi M; Matsushita N; Morino Y; Taira E; Hirose M
    J Pharmacol Sci; 2020 Jan; 142(1):16-25. PubMed ID: 31776072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.